These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 33251324)

  • 1. Effects of a simple cardiac rehabilitation program on improvement of self-reported physical activity in atrial fibrillation - Data from the RACE 3 study.
    Nguyen BO; Wijtvliet EPJP; Hobbelt AH; De Vries SIM; Smit MD; Tieleman RG; Van Veldhuisen DJ; Crijns HJGM; Van Gelder IC; Rienstra M;
    Int J Cardiol Heart Vasc; 2020 Dec; 31():100673. PubMed ID: 33251324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted therapy of underlying conditions improves quality of life in patients with persistent atrial fibrillation: results of the RACE 3 study.
    De With RR; Rienstra M; Smit MD; Weijs B; Zwartkruis VW; Hobbelt AH; Alings M; Tijssen JGP; Brügemann J; Geelhoed B; Hillege HL; Tukkie R; Hemels ME; Tieleman RG; Ranchor AV; Van Veldhuisen DJ; Crijns HJGM; Van Gelder IC
    Europace; 2019 Apr; 21(4):563-571. PubMed ID: 30629160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term outcome of targeted therapy of underlying conditions in patients with early persistent atrial fibrillation and heart failure: data of the RACE 3 trial.
    Nguyen BO; Crijns HJGM; Tijssen JGP; Geelhoed B; Hobbelt AH; Hemels MEW; Mol WJM; Weijs B; Alings M; Smit MD; Tieleman RG; Tukkie R; Van Veldhuisen DJ; Van Gelder IC; Rienstra M;
    Europace; 2022 Jul; 24(6):910-920. PubMed ID: 34791160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted therapy of underlying conditions improves sinus rhythm maintenance in patients with persistent atrial fibrillation: results of the RACE 3 trial.
    Rienstra M; Hobbelt AH; Alings M; Tijssen JGP; Smit MD; Brügemann J; Geelhoed B; Tieleman RG; Hillege HL; Tukkie R; Van Veldhuisen DJ; Crijns HJGM; Van Gelder IC;
    Eur Heart J; 2018 Aug; 39(32):2987-2996. PubMed ID: 29401239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of High-Intensity Interval Training in Patients With Atrial Fibrillation: A Randomized Clinical Trial.
    Reed JL; Terada T; Vidal-Almela S; Tulloch HE; Mistura M; Birnie DH; Wells GA; Nair GM; Hans H; Way KL; Chirico D; O'Neill CD; Pipe AL
    JAMA Netw Open; 2022 Oct; 5(10):e2239380. PubMed ID: 36315143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiarrhythmic drugs in patients with early persistent atrial fibrillation and heart failure: results of the RACE 3 study.
    Al-Jazairi MIH; Nguyen BO; De With RR; Smit MD; Weijs B; Hobbelt AH; Alings M; Tijssen JGP; Geelhoed B; Hillege HL; Tieleman RG; Van Veldhuisen DJ; Crijns HJGM; Van Gelder IC; Blaauw Y; Rienstra M;
    Europace; 2021 Sep; 23(9):1359-1368. PubMed ID: 33899093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of atrial fibrillation on response to exercise-based cardiac rehabilitation in older individuals with heart failure.
    Hamazaki N; Kamiya K; Fukaya H; Nozaki K; Ichikawa T; Matsuzawa R; Yamashita M; Uchida S; Maekawa E; Meguro K; Yamaoka-Tojo M; Matsunaga A; Ako J
    Ann Phys Rehabil Med; 2021 Nov; 64(6):101466. PubMed ID: 33316434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of rate or rhythm control on quality of life in persistent atrial fibrillation. Results from the Rate Control Versus Electrical Cardioversion (RACE) Study.
    Hagens VE; Ranchor AV; Van Sonderen E; Bosker HA; Kamp O; Tijssen JG; Kingma JH; Crijns HJ; Van Gelder IC;
    J Am Coll Cardiol; 2004 Jan; 43(2):241-7. PubMed ID: 14736444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Impact of Cardiac Rehabilitation on Mental and Physical Health in Patients With Atrial Fibrillation: A Matched Case-Control Study.
    Reed JL; Clarke AE; Faraz AM; Birnie DH; Tulloch HE; Reid RD; Pipe AL
    Can J Cardiol; 2018 Nov; 34(11):1512-1521. PubMed ID: 30404754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Routine versus aggressive upstream rhythm control for prevention of early atrial fibrillation in heart failure: background, aims and design of the RACE 3 study.
    Alings M; Smit MD; Moes ML; Crijns HJ; Tijssen JG; Brügemann J; Hillege HL; Lane DA; Lip GY; Smeets JR; Tieleman RG; Tukkie R; Willems FF; Vermond RA; Van Veldhuisen DJ; Van Gelder IC
    Neth Heart J; 2013 Jul; 21(7-8):354-63. PubMed ID: 23700039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality of life and exercise performance in patients in sinus rhythm versus persistent atrial fibrillation: a Veterans Affairs Cooperative Studies Program Substudy.
    Singh SN; Tang XC; Singh BN; Dorian P; Reda DJ; Harris CL; Fletcher RD; Sharma SC; Atwood JE; Jacobson AK; Lewis HD; Lopez B; Raisch DW; Ezekowitz MD;
    J Am Coll Cardiol; 2006 Aug; 48(4):721-30. PubMed ID: 16904540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-reported sleep quality of patients with atrial fibrillation and the effects of cardioversion on sleep quality.
    Kayrak M; Gul EE; Aribas A; Akilli H; Alibasiç H; Abdulhalikov T; Yildirim O; Yazici M; Ozdemir K
    Pacing Clin Electrophysiol; 2013 Jul; 36(7):823-9. PubMed ID: 23437796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of rate versus rhythm control on quality of life in patients with persistent atrial fibrillation. Results from a prospective randomized study.
    Grönefeld GC; Lilienthal J; Kuck KH; Hohnloser SH;
    Eur Heart J; 2003 Aug; 24(15):1430-6. PubMed ID: 12909072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of rate and rhythm control on left ventricular function and cardiac dimensions in patients with persistent atrial fibrillation: results from the RAte Control versus Electrical Cardioversion for Persistent Atrial Fibrillation (RACE) study.
    Hagens VE; Van Veldhuisen DJ; Kamp O; Rienstra M; Bosker HA; Veeger NJ; Tijssen JG; Crijns HJ; Van Gelder IC;
    Heart Rhythm; 2005 Jan; 2(1):19-24. PubMed ID: 15851259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health-related quality of life in patients with atrial fibrillation treated with rhythm control versus rate control: insights from a prospective international registry (Registry on Cardiac Rhythm Disorders Assessing the Control of Atrial Fibrillation: RECORD-AF).
    Ha AC; Breithardt G; Camm AJ; Crijns HJ; Fitzmaurice GM; Kowey PR; Le Heuzey JY; Naditch-Brûlé L; Prystowsky EN; Schwartz PJ; Torp-Pedersen C; Weintraub WS; Dorian P
    Circ Cardiovasc Qual Outcomes; 2014 Nov; 7(6):896-904. PubMed ID: 25387780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement in the quality of life of patients with persistent or long-standing persistent atrial fibrillation after hybrid ablation.
    Osmancik P; Budera P; Talavera D; Herman D; Vesela J; Prochazkova R; Rizov V; Kacer P
    J Interv Card Electrophysiol; 2020 Apr; 57(3):435-442. PubMed ID: 31001766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvement in exercise performance after successful cardioversion in patients with persistent atrial fibrillation and symptoms of heart failure.
    Wozakowska-Kapłon B; Opolski G
    Kardiol Pol; 2003 Sep; 59(9):213-23. PubMed ID: 14618198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of sinus rhythm restoration in patients with persistent atrial fibrillation: a clinical, echocardiographic and hormonal study.
    Wozakowska-Kapłon B; Opolski G
    Int J Cardiol; 2004 Aug; 96(2):171-6. PubMed ID: 15262030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of continuous versus episodic amiodarone treatment on quality of life in persistent atrial fibrillation.
    Ahmed S; Ranchor AV; Crijns HJ; Van Veldhuisen DJ; Van Gelder IC;
    Europace; 2010 Jun; 12(6):785-91. PubMed ID: 20200016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. External electrical and pharmacological cardioversion for atrial fibrillation, atrial flutter or atrial tachycardias: a network meta-analysis.
    Kukendrarajah K; Ahmad M; Carrington M; Ioannou A; Taylor J; Razvi Y; Papageorgiou N; Mead GE; Nevis IF; D'Ascenzo F; Wilton SB; Lambiase PD; Morillo CA; Kwong JS; Providencia R
    Cochrane Database Syst Rev; 2024 Jun; 6(6):CD013255. PubMed ID: 38828867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.